GlassScriptPhysician profile
Joanne H Briggs
NPI 1508940552
$2,736.42
in general payments reported to CMS, 2019-2025
20 companies · $654 in 2025
The $654 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $73.61 · 2021: $124 · 2022: $247 · 2023: $627 · 2024: $732 · 2025: $654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,982 · Education: $17.84 · Entertainment: $12.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,982.36 |
| Education | $17.84 |
| Entertainment | $12.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $409.53 | 2022-2025 | Vyzulta, Miebo, Lotemax Sm |
| Oyster Point Pharma, INC. | $372.85 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Abbvie INC. | $267.01 | 2022-2025 | |
| Glaukos Corporation | $258.76 | 2024-2025 | Idose, Idosetr, Istent Infinite |
| Sun Pharmaceutical Industries INC. | $243.46 | 2019-2025 | Cequa |
| New World Medical,INC. | $186.34 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $164.93 | 2019-2021 | |
| Amgen INC. | $162.97 | 2024-2025 | Tepezza |
| Alcon Vision LLC | $137.44 | 2020-2025 | Rocklatan, Tryptyr |
| Aerie Pharmaceuticals, INC. | $122.04 | 2019 | |
| Mallinckrodt Hospital Products INC. | $93.20 | 2024-2025 | Acthar |
| Allergan, INC. | $70.80 | 2021-2022 | |
| Kala Pharmaceuticals, INC. | $59.91 | 2021-2022 | |
| Dompe US, INC. | $47.74 | 2025 | Oxervate |
| Sight Sciences, INC. | $30.49 | 2024 | Omni Surgical System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $28.73 | 2024 | Vevye |
| Eyevance Pharmaceuticals LLC | $26.80 | 2020-2021 | |
| Tarsus Pharmaceuticals, INC. | $22.72 | 2024 | Xdemvy |
| Thea Pharma INC. | $18.01 | 2023 | Iyuzeh |
| Optos, INC. | $12.69 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanne Briggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.